NIAID's Triple Threat: Closed Doors on Trial Funding
Published Date: 3/19/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 7, 2025, to review important grant applications for clinical trial projects. This meeting affects researchers seeking funding and keeps sensitive info private. It’s a key step in deciding who gets money to fight infectious diseases.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Researchers' Grant Applications Reviewed
If you are a researcher applying for the NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required), your grant application will be reviewed on April 7, 2025 from 12:00 p.m. to 3:30 p.m. at NIAID (video-assisted). This meeting is a formal step in deciding who receives federal funding to support clinical trial projects against infectious diseases.
Confidentiality Protections for Applicants
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information about grant applicants. This keeps sensitive research details and applicant personal data private during the grant review on April 7, 2025.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in